Docket
38471
Apotex Inc., et al. v. Schering Corporation, et al.
(Ontario) (Civil) (By Leave)
Judgments on applications for leave to appeal are rendered by the Court, but are not necessarily unanimous.
Date | Proceeding | Filed By (if applicable) |
---|---|---|
2019-06-04 | Close file on Leave | |
2019-05-17 | Copy of formal judgment sent to Registrar of the Court of Appeal and all parties | |
2019-05-17 | Judgment on leave sent to the parties | |
2019-05-16 | Judgment of the Court on the application for leave to appeal, The application for leave to appeal from the judgment of the Court of Appeal for Ontario, Numbers C65118 and C65129, 2018 ONCA 890, dated November 8, 2018, is dismissed with costs. Dismissed, with costs |
|
2019-04-08 | All materials on application for leave submitted to the Judges, for consideration by the Court | |
2019-03-21 | Certificate (on limitations to public access), (Letter Form), 23B-Reply to Sanofi | Apotex Inc. |
2019-03-21 | Certificate (on limitations to public access), (Letter Form), 23B-Reply to Schering | Apotex Inc. |
2019-02-25 | Applicant's reply to respondent's argument, (Book Form), Reply to Schering, Completed on: 2019-02-22 | Apotex Inc. |
2019-02-22 | Applicant's reply to respondent's argument, (Book Form), Reply to Sanofi, Completed on: 2019-02-22 | Apotex Inc. |
2019-02-13 | Notice of name, (Letter Form) | Schering Corporation |
2019-02-13 | Certificate (on limitations to public access), (Letter Form), 23B | Schering Corporation |
2019-02-13 | Certificate (on limitations to public access), (Letter Form), 23A | Schering Corporation |
2019-02-13 | Respondent's response on the application for leave to appeal, (Book Form), Completed on: 2019-02-13 | Schering Corporation |
2019-02-12 | Notice of name, (Letter Form) | Sanofi-Aventis, Sanofi-Aventis Deutschland GmbH, Sanofi-Aventis Canada Inc. |
2019-02-12 | Certificate (on limitations to public access), (Letter Form), 23B | Sanofi-Aventis, Sanofi-Aventis Deutschland GmbH, Sanofi-Aventis Canada Inc. |
2019-02-12 | Certificate (on limitations to public access), (Letter Form), 23A; Amended certificate required-rec'd 2019/02/19 | Sanofi-Aventis, Sanofi-Aventis Deutschland GmbH, Sanofi-Aventis Canada Inc. |
2019-02-12 | Respondent's response on the application for leave to appeal, (Book Form), Completed on: 2019-02-12 | Sanofi-Aventis, Sanofi-Aventis Deutschland GmbH, Sanofi-Aventis Canada Inc. |
2019-01-16 | Correspondence received from, (Letter Form), Clarification re: counsel for Sanofi | Sanofi-Aventis, Sanofi-Aventis Deutschland GmbH, Sanofi-Aventis Canada Inc. |
2019-01-14 | Letter acknowledging receipt of a complete application for leave to appeal, FILE OPENED 2019/01/14 | |
2019-01-11 | Certificate (on limitations to public access), (Letter Form), 23B | Apotex Inc. |
2019-01-07 | Certificate (on limitations to public access), (Letter Form), 23A; Copy of sealing Order missing-rec'd 2019/01/11 Amended 23A rec'd 2019/02/25 |
Apotex Inc. |
2019-01-07 | Notice of name, (Letter Form) | Apotex Inc. |
2019-01-07 | Application for leave to appeal, (Book Form), (3 volumes), Missing: 23B-rec'd 2019/01/11, CA Order-rec'd 2019/01/11, Completed on: 2019-01-11 | Apotex Inc. |
- Date modified: